Evidence map›Paper›PMID 35967311›Full record

ArticleFrontiers in immunology2022

Polyethylene glycol 20 kDa-induced vacuolation does not impair phagocytic function of human monocyte-derived macrophages.

Anne Schoenbrunn, Kerstin Juelke, Birgit M Reipert, Frank Horling, Peter L Turecek

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Polyethylene Glycols Stimulate CaInternational journal of nanomedicine · 2024
    Article
  5. Fibronectin-targeted FUD and PEGylated FUD peptides for fibrotic diseases.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Anne SchoenbrunnBIH Center for Regenerative Therapies and Institute of Medical Immunology, Charité Universitätsmedizin, Berlin, Germany.
Kerstin JuelkeBIH Center for Regenerative Therapies and Institute of Medical Immunology, Charité Universitätsmedizin, Berlin, Germany.
Birgit M ReipertR&D Baxalta Innovations GmbH, part of Takeda, Vienna, Austria.
Frank HorlingR&D Baxalta Innovations GmbH, part of Takeda, Vienna, Austria.
Peter L TurecekR&D Baxalta Innovations GmbH, part of Takeda, Vienna, Austria.
Takeda (Austria) · ATBerlin Institute of Health at Charité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Conjugation to polyethylene glycol (PEG) is commonly used to enhance drug delivery and efficacy by extending the half-life of the drug molecule. This has important implications for reducing treatment burden in diseases that require chronic prophylaxis, such as hemophilia. Clearance of PEG molecules with high molecular weights (≥ 40 kDa) has been reported to cause cellular vacuolation in mammals. Rurioctocog alfa pegol (PEGylated recombinant coagulation factor VIII) contains a 20-kDa PEG. This study investigated the effects of exposure to 20-kDa PEG (10 μg/ml to 10 mg/ml) on the morphology and function of human monocyte-derived macrophages (MDMs)

Indexed as

Hemophilia APolyethylene GlycolsAnimalsHumansMacrophagesMammalsMolecular WeightRecombinant ProteinsPolyethylene GlycolsRecombinant Proteinsmonocyte-derived macrophagesPEGylated recombinant coagulation factor VIIIpolyethylene glycolrurioctocog alfa pegolvacuolationvacuolization

Identifiers

PMID35967311
PMCPMC9366735
OpenAlexW4288080719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.